GlycoNex Inc.
- Biotech or pharma, therapeutic R&D
GlycoNex is a clinical-stage biotechnology company specializing in innovative antibody therapeutics, with multiple pipelines focused on novel anti-glycan antibody discovery and biosimilar development.
Utilizing a comprehensive antibody development platform, we also offer advanced cell line engineering, cost-effective 200L pilot-scale production, and robust analytical capabilities to ensure the highest product quality.
Address
New Taipei CityTaiwan
Taiwan
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}